BioTime (BTX) and Subsidiary LifeMap Sciences Announce the Launch of LifeMap BioReagents™ Portal  
11/14/2012 9:44:08 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences have announced the launch of LifeMap BioReagents™ (, a new portal offering researchers access to BioTime’s research product lines including PureStem™ human progenitor cell lines, PureStem™ packages, clinical and research grade human embryonic stem cell lines (hES), HyStem® hydrogels, culture media, and cell differentiation kits. LifeMap Sciences will be the principle marketing and sales arm for BioTime’s cell-based products and related reagents for the research community in academia, research hospitals, and biotech and pharma companies. LifeMap Sciences holds the exclusive, worldwide license to market GeneCards® (, with over 12 million page visits per year from hundreds of thousands of unique users worldwide, and MalaCards (, and plans to launch LifeMap Discovery™, its database for biomedical and stem cell research, later this quarter.